The interaction of adenovirus E1A with p
β
Tanya A. Miura; James L. Cook; Terence A. Potter; Sharon Ryan; John M. Routes
π
Article
π
2007
π
John Wiley and Sons
π
English
β 179 KB
## Abstract The use of adenovirus serotype 2 or 5 (Ad2/5) E1A as therapy for human malignancy requires an understanding of the mechanisms involved in E1Aβinduced tumor suppression. The prevailing use of E1A in the treatment of human malignancy stresses the nonβimmunologically mediated, antiβtumorig